Prognostic implications of the phosphatidylinositol 3-kinase/Akt signaling pathway in oral squamous cell carcinoma: overexpression of p-mTOR indicates an adverse prognosis
Author:
Funder
FAPESP
Publisher
Springer Science and Business Media LLC
Link
http://link.springer.com/content/pdf/10.1186/s41241-017-0046-4.pdf
Reference32 articles.
1. Boyle P, Macfarlane GJ, Maisonneuve P, Zheng T, Scully C, Tedesco B. Epidemiology of mouth cancer in 1989: a review. J R Soc Med. 1990;83(11):724–30.
2. Simpson D, Mell L, Cohen E. Targeting the PI3K/AKT/mTOR pathway in squamous cell carcinoma of the head and neck. Oral Oncol. 2014;51(4):291–8.
3. Das BR, Nagpal JK. Understanding the biology of oral cancer. Med Sci Monit. 2002;8(11):RA258–67.
4. Li Q, Wu D, Liu WW, Li H, Liao WG, Zhang XR, et al. Survival impact of cervical metastasis in squamous cell carcinoma of hard palate. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013;116(1):23–7.
5. Williams MD. Integration of biomarkers including molecular targeted therapies in head and neck cancer. Head Neck Pathol. 2010;4(1):62–9.
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. PI3K/AKT/MTOR SIGNALING PATHWAY - A KEY PLAYER IN THE MOLECULAR LANDSCAPE OF MALIGNANT TRANSFORMATION OF ORAL LESIONS;ROM J ORAL REHABIL;2024
2. Exploring the potential of dietary factors and plant extracts as chemopreventive agents in oral squamous cell carcinoma treatment;Frontiers in Oral Health;2023-10-04
3. Role of tissue markers associated with tumor microenvironment in the progression and immune suppression of oral squamous cell carcinoma;Medical Oncology;2023-09-20
4. Synergistic effect of the combination of Chrysanthemum cinerariifolium (Trev.) and doxorubicin in inhibiting PI3K and Cyclin D in oral squamous cell carcinoma: in vitro study;F1000Research;2023-07-25
5. Role of PI3K/AKT pathway in squamous cell carcinoma with an especial focus on head and neck cancers;Cancer Cell International;2022-08-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3